ARROWHEAD PHARMACEUTICALS, INC. 10-Q filing
Filed 2025-08-07 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001628280-25-038858
- Form type
- 10-Q
- CIK
- 0000879407
- Primary document
- https://www.sec.gov/Archives/edgar/data/879407/000162828025038858/arwr-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ARROWHEAD PHARMACEUTICALS, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $573.0M | - | - |
| Operating Income | $54.2M | - | - |
| Net Income | $22.1M | - | - |
| Eps Basic | 0.17 | - | - |
| Eps Diluted | 0.17 | - | - |
| Total Assets | $1.4B | - | - |
| Shareholders Equity | $522.3M | - | - |
| Operating Cash Flow | $159.1M | - | - |
| Capital Expenditures | $15.2M | - | - |